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Purpose.Toreportacaseofgranulomatousanterioruveitiscausedbytravoprost.Methods.Singleobservationalcasereport.Results.
A 71-year-old who was ﬁt and healthy presented with bilateral granulomatous anterior uveitis 2 months after he was started
on travoprost in both eyes. There was no past history of uveitis. Blood test and radiological investigation were unremarkable.
Travoprost was stopped. The uveitis resolved on topical steroid treatment. A rechallenge with travoprost was attempted in one eye.
Theinﬂammationrecurredinthiseyeonly.Thissubsidedwiththecessationoftravoprostalonewithouttopicalsteroid.Conclusion.
This is the ﬁrst case report of travoprost causing granulomatous anterior uveitis. The uveitis recurred with a rechallenge. Changing
the prostaglandin analogue to another topical treatment may be adequate to cease the inﬂammation.
1.Introduction
Prostaglandin analogues are well known to cause non-
granulomatous anterior uveitis. However, bimatoprost and
latanoprost have also been reported to cause granulomatous
anterior uveitis. This is the ﬁrst case report that the latter can
be induced by travoprost as well.
2.CaseReport
A 71-year-old Caucasian gentleman presented with blurry
vision and uncomfortable eyes. His visual acuities were 6/24
in both eyes. He complained his visual had been deteriorat-
ing a fortnight ago. He was started on travoprost 2 months
ago. The treatment was added to dorzolamide to improve
the intraocular pressure (IOP) control. He had bilateral
glaucomatous optic neuropathy, more marked in the left eye.
T h eI O P sw e r e3 4m m H gi nt h er i g h te y ea n d4 5m m H gi n
the left when he was seen in the eye emergency clinic.
He was usually ﬁt and well. He suﬀered from poor hear-
ing since 2 years ago. He was on lisinopril for hypertension
and atorvastatin. He had been taking Systane for dysfunc-
tional tear syndrome twice to four times daily over the past 2
years. There were no other symptoms or signs to elicit.
There were mutton-fat keratic precipitates and 3+ cells
in the anterior chambers with posterior synechiae. Dilated
fundoscopy revealed mild vitritis but no signs of posterior
uveitis. The patient was started on intense topical steroid and
mydrilate. The travoprost was switched to a ﬁxed combina-
tion of brinzolamide and timolol. Oral acetazolamide was
prescribed.
T h ee y e sw e r eq u i e t e ra f t e r3d a y s ,a n dt h eI O P sw e r e
23mmHg in both eyes. A week later, the eyes were quiet, and
therewerelessmutton-fatkeraticprecipitates.TheIOPswere
12 and 14mmHg. He was advised to stop the acetazolamide.
The inﬂammatory markers were normal. The haemo-
globin was slightly below normal at 12.5g/dL, however, the
rest of the full blood count was normal. The results for
immunological screen, inﬂammatory markers, syphilis, tu-
berculosis,toxoplasma,Lymedisease,angiotensinconverting
enzyme, and calcium proﬁle were unremarkable. The chest
X-ray was normal.
A month from the initial presentation, his eyes were
quiet on topical steroid three times daily. The IOPs were
17 and 18mmHg on topical brinzolamide and timolol. The
possibility of the granulomatous anterior uveitis secondary
to travoprost was considered. The steroid was stopped. The
patient agreed to a rechallenge with travoprost in the right
eye only. Both eyes were quiet in the ﬁrst week; however,
the right eye developed 2+ cells in the anterior chamber a
fortnight later. The left eye remained quiet. Travoprost was
stopped.Inthesubsequentvisits,theuveitisresolvedwithout
any topical steroid. The patient’s eyes had been quiet over2 Case Reports in Ophthalmological Medicine
the past 3 months on the ﬁxed brinzolamide and timolol
combination topical treatment.
3. Conclusion
Prostaglandin analogues are well known to cause nongran-
ulomatous anterior uveitis. However, only a handful of
granulomatous anterior uveitis cases have been reported for
latanoprost [1]a n db i m a t o p r o s t[ 2]. To date, there has been
no similar report in the literature for travoprost. However,
the latter has been implicated in nongranulomatous anterior
uveitis [3–5].
The mechanism of induction of intraocular inﬂamma-
tion by prostaglandin analogue has not been entirely clear.
It has been proposed that prostaglandin F2α causes the
release of prostaglandin E2 [6]. This in turn stimulates the
releaseofarachidonicacidbyactivatingphospholipaseII[7].
Arachidonic acid promotes the production of eicosanoids
and other proinﬂammatory mediators in the eye, resulting
in changes in the blood aqueous barriers.
Theimprovementoftheinﬂammationwiththecessation
of travoprost and its recurrence after the rechallenge of
the medication suggest a causal relationship. Based on
the Naranjo algorithm [8] for determining the cause of
an adverse drug reaction, the score for this patient is 9,
which suggests a deﬁnite link between the use of travoprost
and granulomatous anterior uveitis (score of 5–8 implies
a probable link and 9 or more indicate a deﬁnite link).
Althoughthereisapossibilitythatthepatientmaybeallergic
to the preservative component in travoprost (Polyquad),
this remains unlikely since he had used Systane in the past
without any side eﬀect. The artiﬁcial tear also contains the
same preservative found in travoprost. This is the ﬁrst case
report to describe granulomatous anterior uveitis caused by
travoprost.
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